CtBP1 is overexpressed in various types of cancer such as breast, lung, liver, and colorectal cancers, and its upregulation is linked to worse clinical outcomes, including increased tumor growth, invasion, and metastasis, as well as poor response to chemotherapy and radiation therapy [18,40]. Here, CTBP1 is linked to cancer.